AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2023
Jun 8, 2023
34301_dirs_2023-06-08_60865115-e72d-46f1-9a3a-9acffd811638.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2023-06-06
Reporting Person: Clowes Howard (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-06-06 | Common Stock | P | 1000 | $3.98 | Acquired | 4700 | Direct |
More from PLUS THERAPEUTICS, INC.
Capital/Financing Update
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 21
Board/Management Information
2026
Apr 9
Regulatory Filings
2026
Apr 8
Board/Management Information
2026
Mar 26
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27